Novartis AGNVSNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+29.0%
5Y CAGR+11.0%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+29.0%/yr
vs -1.4%/yr prior
5Y CAGR
+11.0%/yr
Recent acceleration
Acceleration
+30.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.07B | +17.4% |
| 2024 | $14.54B | +48.9% |
| 2023 | $9.77B | +22.9% |
| 2022 | $7.95B | -21.0% |
| 2021 | $10.06B | -0.9% |
| 2020 | $10.15B | +11.7% |
| 2019 | $9.09B | +8.1% |
| 2018 | $8.40B | -3.4% |
| 2017 | $8.70B | +5.2% |
| 2016 | $8.27B | - |